Title: Inhibitex is a clinical-stage biopharmaceutical company.
Description: Engages in the discovery, development, and commercialization of new drugs that can prevent and treat serious infections caused by viruses, bacteria and fungi.
Keywords:
Herpes zoster,
shingles,
post-herpetic neuralgia,
PHN,
FV-100,
Staphylococcus aureus,
MRSA,
,
,
cytomegalovirus,
CMV,
HIV,
AIDS,
HCV,
hepatitis C,
biopharmaceutical,
infections,
viruses,
and bacteria.